Merck KGaA foresees post-pandemic localization of biologics supply chains 16-Mar-2021 By Nick Taylor Governments want to 'build up a vaccine and biologics infrastructure locally' to insulate themselves from the sorts of supply disruptions seen in the COVID-19 pandemic, according to Merck KGaA CEO Stefan Oschmann.
